Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/54472
Type
ArticleCopyright
Open access
Sustainable Development Goals
03 Saúde e Bem-EstarCollections
Metadata
Show full item record
PAY FOR PERFORMANCE IN PRIMARY CARE: THE CONTRIBUTION OF THE PROGRAMME FOR IMPROVING ACCESS AND QUALITY OF PRIMARY CARE (PMAQ) ON AVOIDABLE HOSPITALISATIONS IN BRAZIL, 2009–2018
Author
Russo, Letícia Xander
Powell-Jackson, Timothy
Barreto, Jorge Otavio Maia
Borghi, Josephine
Kovacs, Roxanne
Gurgel Junior, Garibaldi Dantas
Gomes, Luciano Bezerra
Sampaio, Juliana
Shimizu, Helena Eri
Sousa, Allan Nuno Alves de
Bezerra, Adriana Falangola Benjamin
Stein, Airton Tetelbom
Silva, Everton Nunes da
Powell-Jackson, Timothy
Barreto, Jorge Otavio Maia
Borghi, Josephine
Kovacs, Roxanne
Gurgel Junior, Garibaldi Dantas
Gomes, Luciano Bezerra
Sampaio, Juliana
Shimizu, Helena Eri
Sousa, Allan Nuno Alves de
Bezerra, Adriana Falangola Benjamin
Stein, Airton Tetelbom
Silva, Everton Nunes da
Affilliation
Federal University of Grande Dourados. Department of Economics. Dourados, MS, Brazil.
London School of Hygiene and Tropical Medicine. Department of Global Health and Development. London, United Kingdom.
Fundação Oswaldo Cruz. Fiocruz Brasília. Brasília, DF, Brasil.
London School of Hygiene and Tropical Medicine. Department of Global Health and Development. London, United Kingdom.
London School of Hygiene and Tropical Medicine. Department of Global Health and Development. London, United Kingdom.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Recife, PE, Brasil
Federal University of Paraiba. Department of Health Promotion. João Pessoa, PB, Brazil.
Federal University of Paraiba. Department of Health Promotion. João Pessoa, PB, Brazil.
University of Brasilia. Department of Collective Health. Brasília, DF, Brazil.
Ministry of Health. Brasilia, DF, Brazil.
Federal University of Pernambuco. Department of Social Medicine. Recife, PE, Brazil.
Federal University of Health Sciences of Porto Alegre. Department of Public Health. Porto Alegre, RS, Brazil.
University of Brasilia. Faculty of Ceilandia. Brasilia, DF, Brazil.
London School of Hygiene and Tropical Medicine. Department of Global Health and Development. London, United Kingdom.
Fundação Oswaldo Cruz. Fiocruz Brasília. Brasília, DF, Brasil.
London School of Hygiene and Tropical Medicine. Department of Global Health and Development. London, United Kingdom.
London School of Hygiene and Tropical Medicine. Department of Global Health and Development. London, United Kingdom.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Recife, PE, Brasil
Federal University of Paraiba. Department of Health Promotion. João Pessoa, PB, Brazil.
Federal University of Paraiba. Department of Health Promotion. João Pessoa, PB, Brazil.
University of Brasilia. Department of Collective Health. Brasília, DF, Brazil.
Ministry of Health. Brasilia, DF, Brazil.
Federal University of Pernambuco. Department of Social Medicine. Recife, PE, Brazil.
Federal University of Health Sciences of Porto Alegre. Department of Public Health. Porto Alegre, RS, Brazil.
University of Brasilia. Faculty of Ceilandia. Brasilia, DF, Brazil.
Abstract
Background Evidence on the effect of pay-for-
performance
(P4P) schemes on provider performance
is mixed in low-income
and middle-income
countries.
Brazil introduced its first national-level
P4P scheme in
2011 (PMAQ-Brazilian
National Programme for Improving
Primary Care Access and Quality). PMAQ is likely one
of the largest P4P schemes in the world. We estimate
the association between PMAQ and hospitalisations for
ambulatory care sensitive conditions (ACSCs) based on a
panel of 5564 municipalities.
Methods We conducted a fixed effect panel data analysis
over the period of 2009–2018, controlling for coverage of
primary healthcare, hospital beds per 10 000 population,
education, real gross domestic product per capita and
population density. The outcome is the hospitalisation rate
for ACSCs among people aged 64 years and under per 10
000 population. Our exposure variable is defined as the
percentage of family health teams participating in PMAQ,
which captures the roll-out
of PMAQ over time. We also
provided several sensitivity analyses, by using alternative
measures of the exposure and outcome variables, and
a placebo test using transport accident hospitalisations
instead of ACSCs.
Results The results show a negative and statistically
significant association between the rollout of PMAQ and
ACSC rates for all age groups. An increase in PMAQ
participating of one percentage point decreased the
hospitalisation rate for ACSC by 0.0356 (SE 0.0123,
p=0.004) per 10 000 population (aged 0–64 years).
This corresponds to a reduction of approximately 60
829 hospitalisations in 2018. The impact is stronger for
children under 5 years (−0.0940, SE 0.0375, p=0.012),
representing a reduction of around 11 936 hospitalisations.
Our placebo test shows that the association of PMAQ
on the hospitalisation rate for transport accidents is not
statistically significant, as expected.
Conclusion We find that PMAQ was associated
Share